Skip to main content

Advertisement

SpringerLink
Log in

Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wendling D, Sondag M, Verhoeven F, Vuitton L, Koch S, Prati C (2018) Arthritis occurrence or reactivation under vedolizumab treatment for inflammatory bowel disease: a four cases report. Joint Bone Spine 85(2):255–256. https://doi.org/10.1016/j.jbspin.2017.01.012

    Article  PubMed  Google Scholar 

  2. Varkas G, Thevissen K, De Brabanter G, Van Praet L, Czul-gurdian F, Cypers H, De Kock J, Carron P, De Vos M, Hindryckx P, Arts J, Vanneuville I, Schoenaers P, Claerhout B, Abreu M, Van den Bosch F, Elewaut D (2017) An induction or flare of arthritis and/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series. Ann Rheum Dis 76:878–881. https://doi.org/10.1136/annrheumdis-2016-210233

    Article  CAS  PubMed  Google Scholar 

  3. Tadbiri S, Peyrin-Biroulet L, Serrero M, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Gilletta C, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier A-L, Bouguen G, Abitbol V, Fumery M, Claudepierre P, Bouhnik Y, Amiot A (2018) Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort. Aliment Pharmacol Ther 47:485–493. https://doi.org/10.1111/apt.14419

    Article  CAS  PubMed  Google Scholar 

  4. Cai T, Lin T-C, Bond A, Huang J, Kane-Wanger G, Cagan A, Murphy SN, Ananthakrishnan AN, Liao KP (2018) The association between arthralgia and vedolizumab using natural language processing. Inflamm Bowel Dis 24(10):2242–2246. https://doi.org/10.1093/ibd/izy127

    Article  PubMed  Google Scholar 

  5. Dubinsky MC, Cross RK, Sandborn WJ, Long M, Song X, Shi N, Ding Y, Eichner S, Brandee Pappalardo B, Ganguli A, Wang A (2018) Extraintestinal manifestations in vedolizumab and anti-TNF-treated patients with inflammatory bowel disease. Inflamm Bowel Dis 24:1876–1882. https://doi.org/10.1093/ibd/izy065

    Article  Google Scholar 

  6. Orlando A, Orlando R, Ciccia F, Renna S, Rizzo a CM, Macaluso FS (2017) Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease. Ann Rheum Dis 76:e31. https://doi.org/10.1136/annrheumdis-2016-211011

    Article  PubMed  Google Scholar 

  7. Colombel JF, Sands BE, Rutgeerts P, Sandborn W, Danese S, D'Haens G, Panaccione R, Loftus EV Jr, Sankoh S, Fox I, Parikh A, Milch C, Abhyankar B, Feagan BG (2017) The safety of vedolizumab for ulcerative colitis and Crohn’s disease. Gut 66:839–851. https://doi.org/10.1136/gutjnl-2015-311079

    Article  CAS  PubMed  Google Scholar 

  8. Kopylov U, Verstockt B, Biedermann L, Sebastian S, Pugliese D, Sonnenberg E, Steinhagen P, Arebi N, Ron Y, Kucharzik T, Roblin X, Ungar B, Shitrit AB, Ardizzone S, Molander P, Coletta M, Peyrin-Biroulet L, Bossuyt P, Avni-Biron I, Tsoukali E, Allocca M, Katsanos K, Raine T, Sipponen T, Fiorino G, Ben-Horin S, Eliakim R, Armuzzi A, Siegmund B, Baumgart DC, Kamperidis N, Maharshak N, Maaser C, Mantzaris G, Yanai H, Christodoulou DK, Dotan I, Ferrante M (2018) Effectiveness and safety of vedolizumab in anti-TNF-naive patients with inflammatory bowel diseases – a multicenter retrospective european study. Inflamm Bowel Dis 24(11):2442–2451. https://doi.org/10.1093/ibd/izy155

    Article  PubMed  Google Scholar 

  9. Macaluso FS, Orlando R, Fries W, Scolaro M, Magnano A, Pluchino D, Cappello M, Morreale GC, Siringo S, Privitera AC, Ferracane C, Belluardo N, Alberghina N, Ventimiglia M, Rizzuto G, Renna S, Cottone M, Orlando A (2018) The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases. Dig Liver Dis 50:675–681. https://doi.org/10.1016/j.dld.2018.02.013

    Article  CAS  PubMed  Google Scholar 

  10. Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, Sørensen IJ, Valle-Oñate R, Weber U, Wei J, Sieper J (2011) The assessment of spondyloarthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25–31. https://doi.org/10.1136/ard.2010.133645

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy

    Silvia Tamanini, Micaela Fredi, Francesca Crisafulli, Maria Grazia Lazzaroni, Angela Tincani & Franco Franceschini

  2. Rheumatology and Clinical Immunology Unit, University of Brescia, 25123, Brescia, Italy

    Micaela Fredi, Francesca Crisafulli, Maria Grazia Lazzaroni, Angela Tincani & Franco Franceschini

Authors
  1. Silvia Tamanini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Micaela Fredi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Crisafulli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Grazia Lazzaroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Angela Tincani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Franco Franceschini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Silvia Tamanini.

Ethics declarations

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tamanini, S., Fredi, M., Crisafulli, F. et al. Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease. Clin Rheumatol 38, 609–610 (2019). https://doi.org/10.1007/s10067-018-4357-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-018-4357-y

Search

Navigation